The role of the pathologist in the management of neuroblastoma, in the context of the team approach to these lesions, is discussed. The importance of the provision of fresh material is stressed, and the prognostic importance of histology and ancillary tests is noted. Participation by the team in a children's cancer study group is a vital component of current and future treatment methods.